Autophagy Activation Protects Ocular Surface from Inflammation in a Dry Eye Model In Vitro

Zhao Liu,Ding Chen,Xin Chen,Fang Bian,Ning Gao,Jinmiao Li,Stephen C. Pflugfelder,De-Quan Li

DOI: https://doi.org/10.3390/ijms21238966

IF: 5.6

2020-11-26

International Journal of Molecular Sciences

Abstract:Inflammation is the main pathophysiology of dry eye, characterized by tear film instability and hyperosmolarity. The aim of this study was to investigate the association of inflammation and cellular autophagy using an in vitro dry eye model with primary cultured human corneal epithelial cells (HCECs). Primary HCECs cultured with fresh limbal explants from donors were switched to a hyperosmotic medium (450 mOsM) by adding sodium chloride into the culture medium. We observed the stimulated inflammatory mediators, TNF-α, IL-1β, IL-6 and IL-8, as well as the increased expression of autophagy related genes, Ulk1, Beclin1, Atg5 and LC3B, as evaluated by RT-qPCR and ELISA. The immunofluorescent staining of LC3B and Western blotting revealed the activated autophagosome formation and autophagic flux, as evidenced by the increased LC3B autophagic cells with activated Beclin1, Atg5, Atg7 and LC3B proteins, and the decreased levels of P62 protein in HCECs. Interestingly, the autophagy activation was later at 24 h than inflammation induced at 4 h in HCECs exposed to 450 mOsM. Furthermore, application of rapamycin enhanced autophagy activation also reduced the inflammatory mediators and restored cell viability in HCECs exposed to the hyperosmotic medium. Our findings for the first time demonstrate that the autophagy activation is a late phase response to hyperosmotic stress, and is enhanced by rapamycin, which protects HCECs by suppressing inflammation and promoting cells survival, suggesting a new therapeutic potential to treat dry eye diseases.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem this paper attempts to address is the inflammatory response induced by hyperosmotic stress in dry eye disease and its relationship with autophagy activation. Specifically, the study aims to investigate the production of inflammatory mediators and the expression changes of autophagy-related genes in human corneal epithelial cells (HCECs) under hyperosmotic conditions (simulated by increasing the concentration of sodium chloride in the medium), and to evaluate the role of autophagy activation in inhibiting inflammation and protecting cells from hyperosmotic stress damage. Additionally, the study explores the effects of the autophagy inducer rapamycin in enhancing autophagy, reducing inflammation, and restoring cell viability.

The main findings of the paper include:
1. **Hyperosmotic stress induces an inflammatory response**: Under hyperosmotic conditions of 450 mOsM, the mRNA expression and protein levels of inflammatory mediators such as TNF-α, IL-1β, IL-6, and IL-8 in HCECs significantly increased.
2. **Autophagy activation is a late response to inflammation**: Hyperosmotic stress significantly activated the expression of autophagy-related genes (such as Ulk1, Beclin1, Atg5, and LC3B) and the formation of autophagosomes after 24 hours, as evidenced by the increase in LC3B-positive cells and LC3B punctate structures, and the decrease in P62 protein levels.
3. **Rapamycin enhances autophagy and reduces inflammation**: With the addition of rapamycin, autophagy activation in HCECs was further enhanced, the secretion of inflammatory mediators was reduced, and cell viability was restored.

These findings provide new insights into the role of autophagy in dry eye disease and suggest that autophagy activation may become a new strategy for the treatment of dry eye disease.